Covered recipient · General Payments record
YUNIOR MARTINEZ DUENAS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$1,231.64
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $528.71 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $148.74 | 14 |
| ViiV Healthcare Company | $102.59 | 5 |
| Novo Nordisk AS | $88.62 | 5 |
| Lilly USA, LLC | $45.59 | 3 |
| GlaxoSmithKline, LLC. | $33.33 | 2 |
| Exact Sciences Corporation | $31.23 | 2 |
| Hologic Sales and Service, LLC | $27.11 | 1 |
| ABBVIE INC. | $21.42 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.78 | 1 |
| PFIZER INC. | $13.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.42 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104976989 | CMS |
| Amgen Inc. | $6.77 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621484 | CMS |
| Amgen Inc. | $4.93 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621486 | CMS |
| Amgen Inc. | $5.44 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621488 | CMS |
| Amgen Inc. | $21.65 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621490 | CMS |
| Amgen Inc. | $7.52 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621492 | CMS |
| Amgen Inc. | $6.57 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621494 | CMS |
| Amgen Inc. | $10.93 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621496 | CMS |
| Amgen Inc. | $9.53 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621498 | CMS |
| Amgen Inc. | $6.85 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621500 | CMS |
| Amgen Inc. | $13.39 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621502 | CMS |
| Amgen Inc. | $13.78 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621504 | CMS |
| Amgen Inc. | $7.02 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621506 | CMS |
| Amgen Inc. | $15.28 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621508 | CMS |
| Amgen Inc. | $19.08 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621510 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.78 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118100650 | CMS |
| Exact Sciences Corporation | $14.82 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114775286 | CMS |
| Exact Sciences Corporation | $16.41 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114775291 | CMS |
| GlaxoSmithKline, LLC. | $19.25 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116219391 | CMS |
| GlaxoSmithKline, LLC. | $14.08 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116350394 | CMS |
| Hologic Sales and Service, LLC | $27.11 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084901896 | CMS |
| Lilly USA, LLC | $15.93 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135511353 | CMS |
| Lilly USA, LLC | $14.13 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135443117 | CMS |
| Lilly USA, LLC | $15.53 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135488808 | CMS |
| Novo Nordisk Inc | $17.32 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096970056 | CMS |
| Novo Nordisk Inc | $14.42 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096612996 | CMS |
| Novo Nordisk Inc | $21.57 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096670521 | CMS |
| Novo Nordisk Inc | $17.68 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097621412 | CMS |
| Novo Nordisk Inc | $17.63 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097812677 | CMS |
| PFIZER INC. | $13.30 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132039588 | CMS |
| ViiV Healthcare Company | $15.49 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112814445 | CMS |
| ViiV Healthcare Company | $22.85 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112763986 | CMS |
| ViiV Healthcare Company | $19.89 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112787338 | CMS |
| ViiV Healthcare Company | $22.42 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112780942 | CMS |
| ViiV Healthcare Company | $21.94 | 12/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112812237 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.